Pharsight

Imvexxy patents expiration

IMVEXXY's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11497709 THERAPEUTICSMD INC NA
Nov, 2032

(9 years from now)

US10537581 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Nov, 2032

(9 years from now)

US11246875 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Nov, 2032

(9 years from now)

US11241445 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Nov, 2032

(9 years from now)

US10835487 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Nov, 2032

(9 years from now)

US9289382 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Nov, 2032

(9 years from now)

US10806697 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Nov, 2032

(9 years from now)

US11351182 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Nov, 2032

(9 years from now)

US11304959 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Nov, 2032

(9 years from now)

US10568891 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Jun, 2033

(9 years from now)

US11123283 THERAPEUTICSMD INC Soluble estradiol capsule for vaginal insertion
Jun, 2033

(9 years from now)

US10888516 THERAPEUTICSMD INC Soluble estradiol capsule for vaginal insertion
Jun, 2033

(9 years from now)

US10471072 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Jun, 2033

(9 years from now)

US11116717 THERAPEUTICSMD INC Soluble estradiol capsule for vaginal insertion
Jun, 2033

(9 years from now)

US11065197 THERAPEUTICSMD INC Soluble estradiol capsule for vaginal insertion
Jun, 2033

(9 years from now)

US10668082 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Jun, 2033

(9 years from now)

US10258630 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Dec, 2033

(10 years from now)

US10398708 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Dec, 2033

(10 years from now)

US9180091 THERAPEUTICSMD INC Soluble estradiol capsule for vaginal insertion
Dec, 2033

(10 years from now)

US11266661 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods
Feb, 2034

(10 years from now)

Imvexxy is owned by Therapeuticsmd Inc.

Imvexxy contains Estradiol.

Imvexxy has a total of 20 drug patents out of which 0 drug patents have expired.

Imvexxy was authorised for market use on 29 May, 2018.

Imvexxy is available in insert;vaginal dosage forms.

Imvexxy can be used as treatment of dyspareunia; treatment of a symptom of vulvar and vaginal atrophy, treatment of a symptom of vulvar and vaginal atrophy; treatment of moderate to severe dyspareunia, treatment of a symptom of vulvar and vaginal atrophy; treatment of dyspareunia.

The generics of Imvexxy are possible to be released after 02 February, 2034.

Drugs and Companies using ESTRADIOL ingredient

Market Authorisation Date: 29 May, 2018

Treatment: Treatment of dyspareunia; Treatment of a symptom of vulvar and vaginal atrophy; Treatment of moderate to severe dyspareunia

Dosage: INSERT;VAGINAL

How can I launch a generic of IMVEXXY before it's drug patent expiration?
More Information on Dosage

IMVEXXY family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic